Partnerships in Education
Memorial University of Newfoundland
Charlotte Penwell Dolimount Memorial Scholarship Recipients
Charlotte Penwell Dolimount Memorial Scholarship Recipients
|
1997-98 Valerie Piercey, Middle Cove
1999-2000 Kristy Boland, Doyles 2001-02 Jaime Marks, Fortune 2003-04 Janet Ralph, Grand Bank 2005-06 Janelle Lake, St. John's 2007-08 Shane Mavin, Fortune 2009-10 Marc Bungay, Grand Bank 2011-12 Cody Hynes, St. John's 2013-14 Daniel Herridge, St. John's 2015-16 Hillary Barnes, Fortune 2017-18. Zachary Mews, Fortune 2019-20 Kiana Stacey, Fortune |
1998-99 Kathryn Stuckey, Fortune
2000-01 David King, Grand Bank 2002-03 Luke Pike, St. John's 2004-05 Cora Herridge, Grand Bank 2006-07 Bradley Prior, Paradise 2008-09 Ryan Simms, Grand Bank 2010-11 Jennifer Lake, Paradise 2012-13 Maria Stone, Red Deer AB 2014-15 Megan Warren, Grand Bank 2016-17 Michael Stone, St. John's 2018-19 Madison Strowbridge, Grand Bank 2020-21 Colin Rose, Fortune |
Spotlight on 2002 Recipient - Luke Pike
Luke completed a Bachelor of Science, joint honours, at MUN in chemistry and biochemistry. He is also the 2007 NL Rhodes Scholar. Through the Rhodes, Luke went on to complete a Ph.D. in medical oncology at Oxford University. After Oxford, Luke pursued a medical degree at the Yale School of Medicine and did further work in translational research with Dr. Peter Glazer, chair of radiation oncology, helping to develop novel therapeutics to target cancer cells that are deficient in certain types of DNA repair. During these years, he was elected to the MUN Board of Regents, serving a three-year term. Since that time, Luke has worked as a resident physician at Harvard University in Boston, splitting his time between the Massachusetts General Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Beth-Israel Deaconess Medical Center, and Boston Children's Hospital. He has authored more than 20 peer review articles in esteemed journals such as Oncogene, Cancer, Cancer Research, JNCCN, and Nature Reviews Clinical Oncology on his work in cancer research. In 2020, Luke was named to the NL Health Innovation Business Advisory Committee which advises Eastern Health’s Living Lab Governance Committee on current and emerging issues/trends related to the development, commercialisation and uptake of innovative technologies and practices.
Luke completed a Bachelor of Science, joint honours, at MUN in chemistry and biochemistry. He is also the 2007 NL Rhodes Scholar. Through the Rhodes, Luke went on to complete a Ph.D. in medical oncology at Oxford University. After Oxford, Luke pursued a medical degree at the Yale School of Medicine and did further work in translational research with Dr. Peter Glazer, chair of radiation oncology, helping to develop novel therapeutics to target cancer cells that are deficient in certain types of DNA repair. During these years, he was elected to the MUN Board of Regents, serving a three-year term. Since that time, Luke has worked as a resident physician at Harvard University in Boston, splitting his time between the Massachusetts General Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Beth-Israel Deaconess Medical Center, and Boston Children's Hospital. He has authored more than 20 peer review articles in esteemed journals such as Oncogene, Cancer, Cancer Research, JNCCN, and Nature Reviews Clinical Oncology on his work in cancer research. In 2020, Luke was named to the NL Health Innovation Business Advisory Committee which advises Eastern Health’s Living Lab Governance Committee on current and emerging issues/trends related to the development, commercialisation and uptake of innovative technologies and practices.
2002 Recipient Luke Pike and guest at the 2004 scholarship reception.